Executive interview: A returnee's perspective

May 21, 2014 Tags: Biotech Business development Pharma Drug development

Dr. Steve Yang is one of the most prominent and well respected "returnees" to China who has helped lead China's evolution toward true innovation. After returning to China eight years ago and leading Asia R&D at two of the big pharma in Shanghai, Dr. Yang has joined one of the companies responsible for that evolution, WuXi AppTec. He is also co-founder of BayHelix, the first cross-border organization of Chinese pharma execs. He brings a unique perspective on the changes in the China life science industry he and WuXi have brought about, especially from a cross-border perspective.

Interviewer: Eric PierceBioCentury

Interviewee: Steve Yang – WuXi AppTec